Page last updated: 2024-10-24

regulation of natural killer cell proliferation

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of natural killer cell proliferation. [GOC:mah]

Natural killer (NK) cell proliferation is a tightly regulated process, crucial for maintaining immune homeostasis and effectively responding to viral infections and tumorigenesis. This regulation involves a complex interplay of signaling pathways, both stimulatory and inhibitory, that are triggered by interactions between NK cells and their target cells.

**Stimulatory Signals:**

* **Cytokine Receptor Engagement:** NK cells express receptors for various cytokines, including IL-2, IL-12, IL-15, and IL-18. Engagement of these receptors triggers downstream signaling pathways, leading to enhanced NK cell proliferation, survival, and effector function.
* **Activating Receptor Engagement:** NK cells possess activating receptors, such as NKG2D, NKp46, and DNAM-1, that recognize stress-induced ligands expressed on target cells. Binding of these receptors initiates intracellular signaling cascades, leading to NK cell activation, degranulation, and proliferation.
* **MHC Class I-Independent Recognition:** NK cells can recognize and kill target cells that lack or express low levels of MHC class I molecules, a mechanism known as "missing self" recognition. This involves inhibitory receptors, such as KIRs and LILRB1, that are normally engaged by MHC class I molecules.

**Inhibitory Signals:**

* **MHC Class I-Dependent Recognition:** Inhibitory receptors on NK cells, such as KIRs and LILRB1, interact with MHC class I molecules expressed on target cells. This interaction delivers inhibitory signals that prevent NK cell activation and cytotoxicity, ensuring self-tolerance.
* **Other Inhibitory Receptors:** NK cells express various other inhibitory receptors, including CD94/NKG2A, that can dampen NK cell activation and proliferation.

**Transcriptional Regulation:**

* **Transcription Factors:** The transcription factors T-bet, Eomes, and STAT4 play crucial roles in regulating NK cell proliferation and differentiation. These factors are activated by cytokine signaling pathways, influencing the expression of genes essential for NK cell function.
* **Epigenetic Modifications:** Epigenetic modifications, such as DNA methylation and histone acetylation, can influence the accessibility of genes involved in NK cell proliferation.

**Key Regulatory Pathways:**

* **PI3K/AKT Pathway:** This pathway is activated by activating receptor engagement and cytokine signaling. It promotes NK cell survival, proliferation, and effector function.
* **MAPK Pathway:** This pathway is also activated by activating receptors and cytokines, leading to increased NK cell proliferation and cytokine production.
* **NF-κB Pathway:** This pathway is involved in regulating NK cell survival, cytokine production, and effector function.

**Regulation of NK Cell Proliferation in Specific Contexts:**

* **Viral Infections:** During viral infections, NK cells proliferate and differentiate into effector cells that can eliminate virus-infected cells. This process is regulated by cytokines, such as IL-12 and IL-15, and by interactions with target cells expressing viral ligands.
* **Tumorigenesis:** NK cells play an important role in anti-tumor immunity. Their proliferation and function are influenced by the tumor microenvironment, including factors such as tumor-associated cytokines, chemokines, and inhibitory molecules.

The intricate regulation of NK cell proliferation ensures the appropriate balance between immune surveillance and self-tolerance. Understanding the molecular mechanisms governing this process is crucial for developing novel therapeutic strategies to enhance NK cell function in cancer and infectious disease settings.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Tyrosine-protein phosphatase non-receptor type 22A tyrosine-protein phosphatase non-receptor type 22 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y2R2]Homo sapiens (human)

Compounds (9)

CompoundDefinitionClassesRoles
lawsonelawsone : 1,4-Naphthoquinone carrying a hydroxy function at C-2. It is obtained from the leaves of Lawsonia inermis.

lawsone: a molluscacide from leaves of Lawsonia inermis L. topical sunscreening agent; structure; powdered leaves of Lawsonia inermis(Lythraceae) used as brown hair dye
1,2-naphthoquinone1,2-naphthoquinone : The parent structure of the family of 1,2-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 2 of the naphthalene ring. It is a metabolite of naphthalene and is found in diesel exhaust particles.

naphthalene-1,2-dione: structure given in first source
1,2-naphthoquinonesaryl hydrocarbon receptor agonist;
carcinogenic agent
1,2-dihydroxynaphthalene1,2-dihydroxynaphthalene: RN given refers to parent cpdnaphthalenediolmouse metabolite
cefsulodincefsulodin : A pyridinium-substituted semi-synthetic, broad-spectrum, cephalosporin antibiotic.

Cefsulodin: A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
cephalosporin;
organosulfonic acid;
primary carboxamide
antibacterial drug
morusinmorusin : An extended flavonoid that is flavone substituted by hydroxy groups at positions 5, 2' and 4', a prenyl group at position 3 and a 2,2-dimethyl pyran group across positions 7 and 8.

morusin: from Morus root bark; structure given in first source
extended flavonoid;
trihydroxyflavone
antineoplastic agent;
plant metabolite
trans-2,3',4,5'-tetrahydroxystilbenetrans-2,3',4,5'-tetrahydroxystilbene: hydroxystilbene oxyresveratrolstilbenoid
Norartocarpetinflavones
cudraflavanone acudraflavanone A: antineoplastic from Cudrania tricuspidata; structure in first source
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source